Skip to main content

Dystonia Medical Research Foundation Honors Two Warren Men for Promoting Awareness of Debilitating Disease

Jason Dunn and Mike Delise recently returned from the Children & Family Dystonia Symposium in Chicago, where they were presented with Star Awards. The Dystonia Medical Research Foundation (DMRF) recognized Dunn and Delise for their efforts to promote greater public awareness of dystonia, a neurological disease.

"I think this is probably the only time in my life that I am speechless," says Dunn. "I wasn't expecting this award at all."

"Bringing awareness and donations to the Dystonia Medical Research Foundation is the single most important thing we can do--this is how a cure will be found," says Delise. "The people who deserve this award are all the people who have dystonia who bring awareness every minute of their life. Jason is my hero and to be able to help your hero is a thrill for me."

Dunn began exhibiting unusual postures and an awkward gait at age 6. While most children this age are mastering their abilities to run, jump, and somersault, Dunn was struggling. Over the next few years, his body was consumed by unrelenting, involuntary muscle spasms that made it difficult or impossible to walk, sit, write, and speak.

When Dunn was in high school, he met and made a powerful impression on Delise, the father of one of Dunn's peers. Delise became an uncle figure and buddy to Dunn, frequently inviting Dunn to his home and sharing his enthusiasm for Detroit sports teams, especially Lions football. Delise has also supported Dunn's desires to promote greater awareness of dystonia by working with local news media and using online social networks. The pair has organized fundraisers on behalf of the DMRF. Because dystonia prevents Dunn from communicating verbally, the two joke that Delise has taken on the role of Dunn's "agent" by making phone calls and coordinating arrangements.

In 2010, Dunn and Delise were featured on the television program, Extraordinary Humans: Muscles, produced by the National Geographic Channel. The program provided a detailed look into how dystonia affects Dunn' daily life. Extraordinary Humans: Muscles was premiered in June 2010 and was re-aired in the following weeks, including internationally and in Spanish, reaching millions of viewers and earning Dunn a large online following.

"Jason and Mike make an impressive team," says DMRF Executive Director Janet Hieshetter. "It takes courage to share your life on national television. They have done an amazing job promoting awareness of dystonia in the Detroit area and around the world."

Dystonia is a movement disorder that causes muscles to contract and spasm involuntarily resulting in twisting, repetitive movements and abnormal postures. Dystonia affects men, women, and children. There is no known cure.

Founded in 1976, the Dystonia Medical Research Foundation is a 501c3 organization whose mission is to advance research toward improved treatments and a cure, promoting education and awareness, and providing support resources to affected individuals and families. The organization can be reached at http://www.dystonia-foundation.org or 800-377-DYST (3978).

Contact: Jessica Feeley, Ph: 912-510-0337, jfeeley@dystonia-foundation.org

Source: Dystonia Medical Research Foundation.

Comments

Popular posts from this blog

Neuronal Switch to Prevent Neurodegenerative Diseases

Scientists at Northwestern University report a surprising discovery that offers a possible new route for the treatment of neurodegenerative diseases. In a study of the transparent roundworm C. elegans, they found that a genetic switch in master neurons inhibits the proper functioning of protective cell stress responses, leading to the accumulation of misfolded and damaged proteins. Neurodegenerative diseases, ranging from Huntington's and Parkinson's to amyotrophic lateral sclerosis and Alzheimer's, are believed to stem from early events that lead to an accumulation of damaged proteins in cells. Yet all animals, including humans, have an ancient and very powerful mechanism for detecting and responding to such damage, known as the heat shock response. "Why are these diseases so widespread if our cells have ways to detect and prevent damaged proteins from accumulating?" said Richard I. Morimoto, who led the research together with postdoctoral colleague Veena Prah...

Blocking Transport Pathway to Prevent Development of Alzheimer's

Blocking a transport pathway through the brain cells offers new prospects to prevent the development of Alzheimer's. Wim Annaert and colleagues of VIB and K.U. Leuven discovered that two main agents involved in the inception of Alzheimer's disease, the amyloid beta precursor protein (APP) and the beta secretase enzyme (BACE1), follow a different path through the brain cells to meet up. It is during the eventual meeting between protein and enzyme that the basis is laid for the development of the disease. The results of the study were published in the Proceedings of the National Academy of Sciences. Wim Annaert suggests that "closing off or rerouting the path which beta secretase follows to get to APP may perhaps be used to inhibit the rise of the disease. However, a great deal of additional research will be necessary to confirm whether this discovery can effectively lead to a drug." APP (red) and BACE1 (pink) follow distinct routes to the early endosome. Blocking s...

Micro-RNA Role in Alzheimer's Disease

Source: Helmholtz Association of German Research Centres . Proteins are the molecular machines of the cell. They transport materials, cleave products or transmit signals -- and for a long time, they have been a main focus of attention in molecular biology research. In the last two decades, however, another class of critically important molecules has emerged: small RNA molecules, including micro-RNAs. It is now well established that micro-RNAs play a key role in the regulation of cell function."A micro-RNA regulates the production of an estimated 300-400 proteins. This class of molecules can be regarded as a switch that coordinates the transition of cells from one state to another," explains Prof. Dr. André Fischer, scientist at the German Center for Neurodegenerative Diseases (DZNE) and Speaker of the DZNE site Göttingen. He and his team have identified a micro-RNA that regulates the learning processes and probably plays a central role in Alzheimer's...